BaroFold is a privately held biopharmaceutical company focused on the development of commercially attractive protein therapeutics for immunology indications. The company's goal is to discover, develop and commercialize protein biologics, some of which incorporate its proprietary PreEMTâ„¢ high pressure folding technology along with other state-of-the-art technologies. This pipeline contains therapeutics with an Immunology focus, including Multiple Sclerosis, Rheumatoid Arthritis, and Asthma.

Research Grants 1 show all


$98.1K
2004

Patents 55show all

  • 35
    C07K - Peptides
  • 17
    C12N - Microorganisms or enzymes
  • 8
    A61K - Preparations for medical, dental, or toilet purposes
  • 6
    C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
  • 5
    B01L - Chemical or physical laboratory apparatus for general use

SEC Filings show all


1
D

Contact Information

12635 E. Montview Blvd Suite 217
Aurora, CO 80045
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$17,400,0001-102013-02-20Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2010-02-23$1,200,000Series Unknown
2013-02-20$1,700,000Series Unknown
2006-03-01$2,500,000Series UnknownBoulder Ventures, The Peierls Foundation
2007-05-29$12,000,000Series AHBM Healthcare Investments AGBoulder Ventures, The Peierls Foundation

SEC Form D Funding Events

DateOfferedSoldType
2013-02-20$1,700,000$1,700,000Equity

Key Executives

  • Matthew Brewer
    Executive Officer, Director
  • Matt Seefeldt
    Executive Officer, Director
  • Kyle Lefkoff
    Director
  • William Freytag
    Director
  • Josh Fidler
    Director